Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...
Hims & Hers Health, Inc. (NYSE:HIMS) shares stumbled Friday afternoon. The company, the leading health and wellness platform, today announced an acquisition that will further verticalize the company’s ...
23 小时on MSN
The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈